The Evidence Speaks (April 2022)
This edition highlights research evaluating patient involvement in clinical trial design, detecting prior COVID-19 infections, and the effect of wildfires on respiratory health
Read MoreThis edition highlights research evaluating patient involvement in clinical trial design, detecting prior COVID-19 infections, and the effect of wildfires on respiratory health
Read MoreThis edition includes emergency contraception use in B.C., overdose following incarceration, and risk factors for hospitalization with COVID
Read MoreCHÉOS Scientists are leading eight of the projects funded in this round, plus a further fourteen projects are supported by CHÉOS Scientists as co-investigators
Read MoreThis edition includes TB screening in people starting dialysis, early opioid dispensing after a lower back injury, and the burden and risk factors for HBV, HCV, and HIV in Rwanda
Read MoreThe results of the CIHR Project Grant Competition for March 2018 were announced today.
Read MoreWork by CHÉOS Scientists on colorectal cancer, treatments for opioid use disorder, and kidney donations was covered by the media in March.
Read MoreA new study from CHÉOS Scientists looks at the underlying factors relating to the recent decline in kidney donation
Read MoreIn recognition of World Kidney Day, read about some of the cutting-edge research by CHÉOS Scientists on the treatment of kidney disease
Read MoreThe twelfth installment in our series, "The Evidence Speaks," highlighting the latest in CHÉOS research.
Read MoreIn August, four CHÉOS Scientists were officially appointed to faculty positions at the University of British Columbia School of Population and Public Health.
Read More